Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-126-4 | CAS number: 10544-72-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The substance is mostly absorbed by inhalation. Absorption occurs mainly in the lower resrpiratory tract. The substance can react with water in the respiratry tract undegoing hydrolysis to nitric and nitrous acid, which have irritating to corrosive properties. The salts of these acids have also been detected in the blood stream and in the urine. Furhtermore, the substance can react with components of the alveolar fluid and epithelial cells, causing lipid membrane peroxidation and cell damage. There is no evidence of the bioaccumulation of the substance in tissues, although some data indicate that the substance can remain in the lungs for a longer period. Excretion is presumed to occur mainly by respiratory route, although salts of nitrous and nitric acidhave also been detected in the urine, suggesting that the substance is also partially excreted via urine.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 0
- Absorption rate - dermal (%):
- 0
- Absorption rate - inhalation (%):
- 100
Additional information
The test item is composed as listed in the Section 2.2. It is a gas and the molecular weight is 92.01 g/mol. Dinitrogen tetraoxide exists in equilibrium with nitrogen dioxide, with ca. 25% present in the form of NO2 at 25 °C. At greater dilution, e.g. with air, the amount of NO2 is greater. Therefore it would seem inevitable that the toxicity studies conducted with either of these gases would share a common mechanism. Therefore read-across from NO2 to its dimer N2O4 is considered to be justified.
Due to the natural state of the material being a gas, inhalation is the most significant potential route of exposure.
Absorption:
Dinitrogen tetraoxide enters the terminal airways via the nose and the upper respiratory tract. In water, dinitrogen tetraoxide reacts slowly to form nitric acid and nitrous acid, both of which have irritating to corrosive effects. In was concluded from the a study with monkeys with radioactively labelled NO2 that nitric acid and nitrous acid are formed also in the respiratory tract (MAK 2005, SCOEL 2014 and references reported therein). In man, 80-90% of NO2 is taken up via the respiratory tract during normal breathing, and over 90% at maximum breathing. Dosimetric model calculations showed that NO2 is absorbed mainly in the lower respiratory tract, where it accumulates particularly in the area between the conductive and respiratory airways (pulmonary acinus), in which the morphological changes are observed (MAK 2005, SCOEL 2014 and references therein).
Distribution:
Systemic distribution can occur following absorption from the lungs into the blood stream. The small molecular size of the material and the equilibrium that forms with nitrous oxide will mean the material can be readily distributed systemically. The nature of the product precludes accumulation in body fat. In the study with monkeys with radioactively labelled NO2, salts of nitric and nitrous acids (nitrates and nitrites) were detected in blood and urine, indicating their absorption and distribution within the body. Experimental studies also showed that NO2 or its products can remain in the lungs for a longer period (MAK 2005, SCOEL 2014 and references reported therein).
Metabolism:
Dinitrogen tetraoxide does not undergo a hepatic or enzymatic metabolism. Instead, the substance reacts slowly with water resulting in the formation of nitric and nitrous acids, the salts of which have been detected in blood and urine of experimental animals (MAK 2005, SCOEL 2014 and references therein). Furthermore, a monomer of dinitrogen tetraoxide, NO2, is a free radical, which can react with components of the alveolar fluid and the epithelial cells in different ways, causing lipid membrane peroxidation and oxidative cell damage. The concentration dependence of the oxidative cell damage is determined by the antioxidative capacity of the alveolar fluid and the target cells.
Excretion:
As the route of administration is inhalation, it is likely that the route of excretion is via respiration for this or any gaseous breakdown products. However, the salts of nitrous and nitric acids were detected in urine of experimental animals (monkeys), suggesting that the substance is also partially excreted via urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.